These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15711104)

  • 41. Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction.
    Zlotta AR; Djavan B; Marberger M; Schulman CC
    J Urol; 1997 Apr; 157(4):1315-21. PubMed ID: 9120930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Relation of age and prostatic volume to cancer detection in prostatic biopsies from patients with non-suspect rectal palpation].
    Herranz Amo F; Verdú Tartajo F; Díez Cordero JM; Subira Ríos D; Castaño González I; Moralejo Gárate M; Martínez Salamanca JI; Cabello Benavente R
    Arch Esp Urol; 2003 May; 56(4):359-66. PubMed ID: 12830608
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with prostate specific antigen levels of 4.1-10.0 ng/mL.
    Ito K; Ohi M; Yamamoto T; Miyamoto S; Kurokawa K; Fukabori Y; Suzuki K; Yamanaka H
    Cancer; 2002 Nov; 95(10):2112-9. PubMed ID: 12412164
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Importance of prostate volume for detection of prostate cancer by first sextant biopsy in high-risk patients].
    Vaiciūnas K; Auskalnis S; Matjosaitis A; Trumbeckas D; Jievaltas M
    Medicina (Kaunas); 2007; 43(4):285-90. PubMed ID: 17485955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
    Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
    Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Early diagnosis of prostatic carcinoma by random biopsies in 60 patients clinically negative but with PSA greater than 8.9 ng/ml].
    Bianchi A; Bottanelli A; Baroni G; Rovellini P; Sciaraffia G; Toia G; Marcelli G
    Arch Ital Urol Androl; 1997 Dec; 69(5):313-8. PubMed ID: 9477617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical, biochemical and pathological features of initial and repeat transrectal ultrasonography prostate biopsy positive patients.
    Yuen JS; Lau WK; Ng LG; Tan PH; Khin LW; Cheng CW
    Int J Urol; 2004 Apr; 11(4):225-31. PubMed ID: 15028101
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An extended 10-core transrectal ultrasonography guided prostate biopsy protocol improves the detection of prostate cancer.
    Eskicorapci SY; Baydar DE; Akbal C; Sofikerim M; Günay M; Ekici S; Ozen H
    Eur Urol; 2004 Apr; 45(4):444-8; discussion 448-9. PubMed ID: 15041107
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Critical evaluation of the current indications for transition zone biopsies.
    Liu IJ; Macy M; Lai YH; Terris MK
    Urology; 2001 Jun; 57(6):1117-20. PubMed ID: 11377321
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Role of ultrasonography-guided prostatic biopsy of hypoechoic areas associated with systematic biopsies in patients with normal and high PSA levels].
    Scattoni V; Roscigno M; Raber M; Consonni P; Freschi M; Montorsi F; Pasta A; Colombo R; Nava L; Bua L; Rigatti P
    Arch Ital Urol Androl; 2002 Dec; 74(4):273-5. PubMed ID: 12508749
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of transition zone sampling by TURP in patients with raised PSA and multiple negative transrectal ultrasound-guided prostatic biopsies.
    Radhakrishnan S; Dorkin TJ; Sheikh N; Greene DR
    Prostate Cancer Prostatic Dis; 2004; 7(4):338-42. PubMed ID: 15365579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prostate cancer in the transition zone in sympatomatic patients with no rectal signs and negative peripheral zone biopsy].
    Herranz Amo F; Díez Cordero JM; Verdú Tartajo F; Bueno Chomón G; Leal Hernández F; Bielsa Carrillo A; García Burgos J
    Arch Esp Urol; 1998 Jun; 51(5):437-41. PubMed ID: 9675938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Location of Prostate Cancers Determined by Multiparametric and MRI-Guided Biopsy in Patients With Elevated Prostate-Specific Antigen Level and at Least One Negative Transrectal Ultrasound-Guided Biopsy.
    Schouten MG; Hoeks CM; Bomers JG; Hulsbergen-van de Kaa CA; Witjes JA; Thompson LC; Rovers MM; Barentsz JO; Fütterer JJ
    AJR Am J Roentgenol; 2015 Jul; 205(1):57-63. PubMed ID: 26102380
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
    Iwaki H; Kajita Y; Shimizu Y; Yamauchi T
    Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The role of power Doppler-guided prostatic biopsy in the diagnosis of prostate cancer].
    Okihara K; Kojima M; Nakanouchi T; Okada K; Miki T
    Hinyokika Kiyo; 1999 Aug; 45(8):559-63. PubMed ID: 10500963
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The value of percent free prostate specific antigen, prostate specific antigen density of the whole prostate and of the transition zone in Turkish men.
    Akduman B; Alkibay T; Tuncel A; Bozkirli I
    Can J Urol; 2000 Oct; 7(5):1104-9. PubMed ID: 11114873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Diagnostic value of 10 systematized and ultrasound-guided transrectal prostatic biopsies].
    Ravery V; Billebaud T; Toublanc M; Boccon-Gibod L; Hermieu JF; Moulinier F; Blanc E; Delmas V; Boccon-Gibod L
    Prog Urol; 1998 Dec; 8(6):1012-7. PubMed ID: 9894260
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies.
    Dimmen M; Vlatkovic L; Hole KH; Nesland JM; Brennhovd B; Axcrona K
    BJU Int; 2012 Jul; 110(2 Pt 2):E69-75. PubMed ID: 22093091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic value of ten systematic TRUS-guided prostate biopsies.
    Ravery V; Billebaud T; Toublanc M; Boccon-Gibod L; Hermieu JF; Moulinier F; Blanc E; Delmas V; Boccon-Gibod L
    Eur Urol; 1999 Apr; 35(4):298-303. PubMed ID: 10087392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. Prostate specific antigen.
    Lodding P; Aus G; Bergdahl S; Frösing R; Lilja H; Pihl CG; Hugosson J
    J Urol; 1998 Mar; 159(3):899-903. PubMed ID: 9474178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.